Argonne researchers find 217 new targets for anticancer drugs

By identifying novel genes critical to cancer progression, biologists at the U.S. Department of Energy's Argonne National Laboratory have expanded the number of drug targets researchers have available for study to find ways to stop tumors in their tracks. The report is published today in Cancer Research.

Argonne researchers find 217 new targets for anticancer drugs